Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lexston announces change of Auditor

C.LEXT

(TheNewswire)

Lexston Life Sciences Corp.

Vancouver, British Columbia – TheNewswire - June 28, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announced today that its board of directors has approved a change of the Company’s auditors. At the request of the Company, Saturna Group Chartered Professional Accountants LLP (the “Former Auditor”) has resigned as auditor of the Company effective June 27, 2023. The audit committee and board of directors of the Company have appointed WDM Chartered Professional Accountants as the successor auditor, effective June 27, 2023 (the “Successor Auditor”) until the close of the next annual general meeting of the Company.

The Company has sent a Notice of Change of Auditor (the “Notice”) to the former Auditor and to the Successor Auditor and has received a letter from each, addressed to the securities commissions in each of Ontario, Alberta and British Columbia and the Canadian Securities Exchange stating that they agree with the information contained in the Notice. The Notice together with the letter from the Former Auditor and the letter from the Successor Auditor have been reviewed by the Company’s audit committee and its board of directors and are available on www.sedar.com.

There were no disagreements or unresolved issues with the Former Auditor on any matter of audit scope or procedures, accounting principles or policies, or financial statement disclosure. It is the Company’s opinion that there have been no “reportable events” (as defined in National Instrument 51-102 Continuous Disclosure Obligation) between the Company and the Former Auditor. The Former Auditor did not provide a modified opinion in their auditor’s report for the financial statements of the Company fiscal years ended May 31, 2022 and 2021.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal, Chief Executive Officer

Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Copyright (c) 2023 TheNewswire - All rights reserved.

Tags: